Continuous preparation of polymer coated drug crystals by solid hollow fiber membrane-based cooling crystallization

International Journal of Pharmaceutics
Dengyue ChenRobert Pfeffer

Abstract

A facile way to continuously coat drug crystals with a polymer is needed in controlled drug release. Conventional polymer coating methods have disadvantages: high energy consumption, low productivity, batch processing. A novel method for continuous polymer coating of drug crystals based on solid hollow fiber cooling crystallization (SHFCC) is introduced here. The drug acting as the host particle and the polymer for coating are Griseofulvin (GF) and Eudragit RL100, respectively. The polymer's cloud point temperature in its acetone solution was determined by UV spectrophotometry. An acetone solution of the polymer containing the drug in solution as well as undissolved drug crystals in suspension were pumped through the tube side of the SHFCC device; a cold liquid was circulated in the shell side to rapidly cool down the feed solution-suspension in the hollow-fiber lumen. The polymer precipitated from the solution and coated the suspended crystals due to rapid temperature reduction and heterogeneous nucleation; crystals formed from the solution were also coated by the polymer. Characterizations by scanning electron microscopy, thermogravimetric analysis, laser diffraction spectroscopy, X-ray diffraction, Raman spectroscopy, and di...Continue Reading

References

Sep 28, 1990·Science·R Langer
Mar 10, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·A Bernkop-SchnürchR G Biebel
Dec 5, 2002·Foot and Ankle Clinics·Anand Vora, Mark S Myerson
Jan 17, 2004·International Journal of Pharmaceutics·J Schulze NahrupA Sakr
Nov 18, 2005·Journal of Colloid and Interface Science·Mattias Paulsson, Katarina Edsman
Aug 30, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·David A FluriMartin Fussenegger
Jan 10, 2009·Advanced Drug Delivery Reviews·Samuel K LaiJustin Hanes
Oct 7, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yoshinori KakizawaNobuo Ida
Nov 3, 2010·International Journal of Pharmaceutics·Min-Jeong LeeGuang J Choi
Mar 1, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Richard LagaLen W Seymour
Jun 13, 2012·Acta Biomaterialia·Sanjib BhattacharyyaPaul Ducheyne
Jul 24, 2012·International Journal of Pharmaceutics·Adi GhebaurHoria Iovu
Aug 31, 2012·Science Translational Medicine·Elizabeth A NanceJustin Hanes
Mar 13, 2014·International Journal of Pharmaceutics·Varsha SundaresanAniket S Wadajkar
Jun 7, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Dengyue ChenRobert Pfeffer
Sep 23, 2014·International Journal of Pharmaceutics·R Wulff, C S Leopold
Oct 8, 2014·International Journal of Pharmaceutics·Liang LiShirui Mao
Jan 2, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Dengyue ChenRobert Pfeffer

❮ Previous
Next ❯

Citations

Aug 29, 2021·Polymers·Marcin LemanowiczAndrzej Gierczycki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved